These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9134631)
21. Increased venous versus arterial thrombosis in the Factor V Leiden mouse. Cooley BC; Chen CY; Schmeling G Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123 [TBL] [Abstract][Full Text] [Related]
22. Clinical manifestations in thrombotic children with factor V Leiden mutation. Gurgey A Pediatr Hematol Oncol; 1999; 16(3):233-7. PubMed ID: 10326221 [TBL] [Abstract][Full Text] [Related]
23. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831 [TBL] [Abstract][Full Text] [Related]
24. [Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients]. Nagy A; Melegh B; Losonczy H Orv Hetil; 1997 Nov; 138(44):2797-800. PubMed ID: 9411348 [TBL] [Abstract][Full Text] [Related]
25. [Clinical findings in individuals with the factor V Leiden mutation]. Matýsková M; Vorlová Z; Hrachovinová I; Buliková A; Zavrelová J; Slechtová M Vnitr Lek; 1997 May; 43(5):298-301. PubMed ID: 9601852 [TBL] [Abstract][Full Text] [Related]
26. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Kontula K; Ylikorkala A; Miettinen H; Vuorio A; Kauppinen-Mäkelin R; Hämäläinen L; Palomäki H; Kaste M Thromb Haemost; 1995 Apr; 73(4):558-60. PubMed ID: 7495058 [TBL] [Abstract][Full Text] [Related]
27. Factor V Leiden mutation in patients with Behçet's disease. Oner AF; Gürgey A; Gürler A; Mesci L J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770 [TBL] [Abstract][Full Text] [Related]
28. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310 [TBL] [Abstract][Full Text] [Related]
29. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167 [TBL] [Abstract][Full Text] [Related]
30. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Cushman M; Rosendaal FR; Psaty BM; Cook EF; Valliere J; Kuller LH; Tracy RP Thromb Haemost; 1998 May; 79(5):912-5. PubMed ID: 9609219 [TBL] [Abstract][Full Text] [Related]
31. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Kim RJ; Becker RC Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985 [TBL] [Abstract][Full Text] [Related]
32. Age as a risk factor for myocardial infarction in Leiden mutation carriers. Baranovskaya S; Kudinov S; Fomicheva E; Vasina V; Solovieva D; Khavinson V; Schwartz E Mol Genet Metab; 1998 Jun; 64(2):155-7. PubMed ID: 9705241 [TBL] [Abstract][Full Text] [Related]
33. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141 [TBL] [Abstract][Full Text] [Related]
34. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency. Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428 [TBL] [Abstract][Full Text] [Related]
35. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075 [TBL] [Abstract][Full Text] [Related]
36. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis. Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462 [TBL] [Abstract][Full Text] [Related]
37. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
38. Homozygous factor V Leiden mutation and disseminated thrombosis in a patient with nephrotic syndrome. Kahveci A; Seyahi N; Seyahi E; Altiparmak MR; Ataman R; Serdengecti K J Nephrol; 2007; 20(1):103-6. PubMed ID: 17347983 [TBL] [Abstract][Full Text] [Related]
39. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407 [TBL] [Abstract][Full Text] [Related]